“IBA” Proteus 235 Proton Therapy System and accessories Proteus®PLUS
IBA Proteus®PLUS is designed to generate and deliver proton beams for the treatment of patients with malignant tumors in the head, neck and body parts.
IBA’s PROTEUS®PLUS is a tailor-made proton therapy solution focusing on helping clinical teams to deliver the most effective treatment, using the latest clinical innovations, including Image-Guided Intensity ModuIated Proton Therapy (IMPT). IMPT lets radiation oncologists adjust the precision, depth and intensity of a proton beam to the
The Proteus PLUS is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation.
IBA announces strategic licensing deal for Proteus®PLUS in …
2020年8月26日 · IBA’s Proteus®PLUS is tailored, scalable, and leading-edge solution configured for excellence. It is a made-to-measure, image-guided, intensity-modulated, proton beam technology which enables a proton therapy center to treat more patients suffering from the broadest array of complex cancer conditions.
partner CGN Medical Technology (CGNMT) for IBA’s Proteus®PLUS1 proton therapy system, with one gantry treatment room to be installed at the West China International Cancer Treatment Center in Chengdu, Sichuan Province.
IBA signs €100m licensing deal for proton therapy solution in …
2020年8月27日 · Ion Beam Applications (IBA) has signed a strategic licensing deal with CGN Nuclear Technology Development (CGNNT) and its subsidiary CGN Dasheng for the exclusive rights to its Proteus PLUS technology in China.
IBA to Install Proton Therapy Facility at the Inova Schar Cancer ...
2017年7月5日 · Contract signed with Inova for two-room Proteus ® PLUS* proton therapy system near IBA’s North American Headquarters
IBA signs contract with partner CGN Medical Technology for the ...
CGNMT is the sole proton therapy system vendor for West China International Cancer Treatment Center in Chengdu. Following the strategic licensing agreement signed between IBA and CGNNT in 2020, IBA provides the key components of the Proteus®PLUS system to CGNMT which will be installed at the hospital site.
IBA Receives Down Payment for a Proteus®PLUS System in China
2021年8月12日 · This IBA open platform system will integrate the latest state of the art Proteus®PLUS technologies such as Pencil Beam Scanning (PBS), Cone Beam Computed Tomography (CBCT) and Motion Management (interplay assessment and imaging for …
IBA licenses its ProteusPLUS technology to CGNNT for $118m
2020年8月27日 · Ion Beam Applications (IBA), a provider of proton therapy solutions for cancer, has reached a licensing agreement with CGN Nuclear Technology Development (CGNNT), for the exclusive rights to its ProteusPLUS technology in China.
- 一些您可能无法访问的结果已被隐去。显示无法访问的结果